J. David Furlow

image of J. David Furlow



Neurobiology, Physiology and Behavior

Offices and Labs

274B Briggs Hall
(530) 754-8609

Profile Introduction

Molecular basis of hormone action, particularly during development


1992 PhD (Biochemistry) University of Wisconsin, Madison
1985 BS (Biochemistry) Pennsylvania State University
Postdoctoral Fellow - Carnegie Institution of Washington, Department of Embryology

Research Interests

Hormones and Development

Molecular basis of hormone action, particularly during development. Analysis of gene expression programs during morphogenesis. Genome editing in model organisms, particularly applied to nuclear hormone receptor function.


Whitman Fellow, Marine Biological Laboratory Woods Hole, MA 2014 and 2015
Visiting faculty, European Molecular Biology Laboratory, Heidelberg, Germany 2006

Department and Center Affiliations

UCD Cancer Center
Faculty, Physiology course, Marine Biological Laboratory, Woods Hole, MA


The Endocrine Society
Society for Developmental Biology
American Physiological Society

CBS Grad Group Affiliations

Biochemistry, Molecular, Cellular and Developmental Biology
Molecular, Cellular, and Integrative Physiology

Specialties / Focus

Biochemistry, Molecular, Cellular and Developmental Biology
  • Cellular Responses to Toxins and Stress
  • Genomics, Proteomics and Metabolomics
Molecular, Cellular, and Integrative Physiology
  • Molecular Physiology
  • Comparative Physiology
  • Endocrinology
  • Developmental Physiology


Furlow Lab, 274 Briggs Hall
  • Brenda Mengeling

Teaching Interests

Endocrinology, developmental biology, molecular biology.


NPB 101 Systemic Physiology (Winter)
NPB 128 Comparative Physiology: Endocrinology (Winter)
NPB 152 Hormones and Behavior (Spring)

Personal Interests

Travel, reading, movies, volleyball, gardening (ok, not that last one!).


9/20/2015 4:25:07 PM
  • Bodine SC, Furlow JD. Glucocorticoids and Skeletal Muscle. Adv Exp Med Biol. 2015;872:145-76.

  • Mengeling BJ, Furlow JD. Pituitary specific retinoid-X receptor ligand interactions with thyroid hormone receptor signaling revealed by high throughput  reporter and endogenous gene responses. Toxicol In Vitro. 2015 Oct;29(7):1609-18.

  • Freitas J, Miller N, Mengeling BJ, Xia M, Huang R, Houck K, Rietjens IM, Furlow JD, Murk AJ. Identification of thyroid hormone receptor active compounds using a quantitative high-throughput screening platform. Curr Chem Genom Transl Med. 2014 Mar 7;8:36-46

  •  Furlow JD, Watson ML, Waddell DS, Neff ES, Baehr LM, Ross AP, Bodine SC. Altered gene expression patterns in muscle ring finger 1 null mice during denervation- and dexamethasone-induced muscle atrophy. Physiological Genomics. 2013 Dec 1;45(23):1168-85. 

  • Gomes AV, Waddell DS, Siu R, Stein M, Dewey S, Furlow JD, Bodine SC. (2012) Upregulation of proteasome activity in muscle RING finger 1-null mice following denervation. FASEB J. Jul;26(7):2986-99.
  • Murk AJ, Rijntjes E, Blaauboer BJ, Clewell R, Crofton KM, Dingemans MM, Furlow JD, Kavlock R, Köhrle J, Opitz R, Traas T, Visser TJ, Xia M, and AC Gutleb (2013) Mechanism-based testing strategy using in vitro approaches for identification of thyroid hormone disrupting chemicals. Toxicology In Vitro. 27(4):1320-1346
  • Furlow JD, Watson ML, Waddell DS, Neff ES, Baehr LM, Ross AP, and SC Bodine. (2013) Altered gene expression patterns in muscle ring finger 1 null mice during denervation- and dexamethasone-induced muscle atrophy. Physiological Genomics 45(23):1168-1185.
  • Watson ML, Baehr LM, Reichardt HM, Tuckermann JP, Bodine SC, Furlow JD. (2012) A cell-autonomous role for the glucocorticoid receptor in skeletal muscle atrophy induced by systemic glucocorticoid exposure. Am J Physiol Endocrinol Metab. May 1;302(10):E1210-20.
  • Files DC, D'Alessio FR, Johnston LF, Kesari P, Aggarwal NR, Garibaldi BT, Mock JR, Simmers JL, DeGorordo A, Murdoch J, Willis MS, Patterson C, Tankersley CG, Messi ML, Liu C, Delbono O, Furlow JD, Bodine SC, Cohn RD, King LS, Crow MT. (2012) A critical role for muscle ring finger-1 in acute lung injury-associated skeletal muscle wasting. Am J Respir Crit Care Med. Apr 15;185(8):825-34.
  • Baehr LM, Furlow JD, Bodine SC. (2011) Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids. J Physiol. Oct 1;589(Pt 19):4759-76.
  • Freitas J, Cano P, Craig-Veit C, Goodson ML, Furlow JD, Murk AJ. (2011) Detection of thyroid hormone receptor disruptors by a novel stable in vitro reporter gene assay. Toxicol In Vitro. Feb;25(1):257-66.
  • Denver, RJ, Scanlan TS, and JD Furlow (2009) Thyroid hormone receptor subtype specificity for hormone-dependent neurogenesis in Xenopus laevis. Developmental Biology (in press).
  • Johnsen SA, Güngör C, Prenzel T, Riethdorf, S, Riethdorf L, Taniguchi-Ishigaki N, Rau T, Tursun B, Furlow JD, Sauter G, Scheffner M, Pantel K, Gannon F, and I Bach. (2009) Identification of the LIM cofactors CLIM and RLIM as Novel Regulators of Estrogen-Dependent Transcription in Breast Cancer. Cancer Research. 69:128-136
  • Waddell DS, Baehr LM, van der Brandt J, Johnsen SA, Reichardt HM, Furlow JD, and SC Bodine (2008) The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy related MuRF1gene. American Journal of Physiology: Endocrinology and Metabolism. 295:E785-797
  • Schriks M, Roessig JM, Murk AJ, Furlow JD (2007) Thyroid hormone receptor isoform selectivity of thyroid hormone disrupting compounds quantified with an in vitro reporter gene assay. Environmental Toxicology and Pharmacology 23:320-307.
  • Weidner WJ, Waddell DS, Furlow JD. (2006) Measurement of the filtration coefficient (Kfc) in the lung of Gallus domesticus and the effects of increased microvascular permeability. J Comp Physiol [B] 176(6):567-574
  • Furlow, J.D. and E.S. Neff (2006) A developmental switch induced by thyroid hormone: Xenopus laevis metamorphosis. Trends in Endocrinolology and Metabolism 17:40-47.
  • Schriks M, Zvinavashe E, Furlow JD, Murk AJ. (2006) Disruption of thyroid hormone-mediated Xenopus laevis tadpole tail tip regression by hexabromocyclododecane (HBCD) and 2,2',3,3',4,4',5,5',6-nonabrominated diphenyl ether (BDE206). Chemosphere. 65:1904-1908.
  • Lim, W., Neff, E. S., and J. D. Furlow (2004) The mouse muscle creatine kinase promoter faithfully drives reporter gene expression in transgenic Xenopus laevis. Physiological Genomics. 18:79-86
  • Furlow J. D., Yang, H. Y., Hsu, Y. M., Lim, W., Ermio, D. J., Chiellini, G., and T. S. Scanlan (2004) The thyroid hormone receptor agonist GC-1 preferentially induces tissue resorption in Xenopus laevis tadpoles. Journal of Biological Chemistry. 279:26555-26562
  • Luria, A. and J. D. Furlow (2004) Spatiotemporal activation of retinoid-X receptors detected in live vertebrate embryos. Proceedings of the National Academy of Sciences. 101:8987-8992
  • Lim, W, Nguyen, NH, Yang, HY, Scanlan, TS, and JD Furlow (2002) A thyroid hormone antagonist that inhibits thyroid hormone action in vivo. Journal of Biological Chemistry 277:35664-35670
  • Lim, W, and JD Furlow (2002) Ribozyme suppression of endogenous thyroid hormone receptor activity in Xenopus laevis cells. Nucleic Acids Research 30:3490-3496
  • Furlow, JD and A Kanamori (2002) The Transcription Factor Basic Transcription Element-Binding Protein 1 is a Direct Thyroid Hormone Response Gene in the Frog Xenopus laevis. Endocrinology. 143:3295-3305